首页> 外国专利> Production of medicinal plants to animals and subsequent human

Production of medicinal plants to animals and subsequent human

机译:向动物和随后的人类生产药用植物

摘要

Production of medicinal plants, animals and later for humans.Understood that the syrup plants extracts and natural ingredients extracted from our flora and in the following proportion; 111,12 ml of extract liquid of dried leaves of acquired EMBA u00fa Ba, and the roots, stems, leaves and seeds of the grab Pinto and break stone, collected on the same day, More 66,67 ml of extract of aloes, mastruz and green leaves of EMBA u00fa Ba, and 44.44 ml of the extract of top white with grain alcohol and 55,55 ml of tincture of jalapa, more 222,22 ml of honey bees and cane sugar in equal parts. Has the power to treat many kinds of infections, including leishmaniasis (Kala Azar), the same being an immunosuppressant for other types of products.The treatment can be done only at the base of the syrup plants or associated with other types of products, the duration of treatment will vary from animal to animal.The syrup plants will be available in bottles of 500 ml, and will be produced in capsules, ointments, first will be used following vet for treatment of dogs and later also used in the treatment in humans.
机译:生产药用植物,动物以及后来用于人类的产品。了解到糖浆植物是从我们的植物群中提取的,并且其提取比例如下:当天收集的111,12 ml获得的EMBA uBafa干叶的提取液以及抓斗Pinto和碎石的根,茎,叶和种子,更多66,67 ml芦荟提取物, EMBA的Masruz和绿叶,以及44.44 ml的顶部提取物和谷物酒精和55,55 ml的哈拉帕tin剂,以及等量的222,22 ml蜜蜂和蔗糖。具有治疗多种感染的能力,包括利什曼病(Kala Azar),它是其他类型产品的免疫抑制剂,只能在糖浆厂或与其他类型产品相关的地方进行治疗糖浆植物将以500毫升的瓶装出售,并以胶囊,软膏形式生产,首先将在兽医后用于狗的治疗,后来也用于人类的治疗。

著录项

  • 公开/公告号BRPI0604885A

    专利类型

  • 公开/公告日2008-02-19

    原文格式PDF

  • 申请/专利权人 JOAO EVANGELISTA DE SOUSA;

    申请/专利号BR2006PI04885

  • 申请日2006-06-20

  • 分类号A61K36/886;A23L21/25;A61K36/39;A61K36/47;A61K36/60;A61K36/61;A61P33/02;

  • 国家 BR

  • 入库时间 2022-08-21 20:08:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号